CARACAS (Reuters) - Venezuela is risking further delays to an already stalled COVID-19 vaccination campaign by seeking to use specific brands of vaccines while shunning readily available ones, opposition leader Juan Guaido said on Wednesday.
The COVAX global vaccine program has offered to sell doses of the AstraZeneca vaccine to Venezuela, pending a payment arrangement, but the government of President Nicolas Maduro blocked its use following concerns about blood clotting.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!